Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
about
The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in OsteoporosisThe role of microRNAs in bone remodelingA randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityDevelopments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice.Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway.Wnts' fashion statement: from body stature to dysplasia.Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Romosozumab for the treatment of osteoporosis.Role of WNT16 in the regulation of periosteal bone formation in female mice.Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.A comparison of tissue engineering based repair of calvarial defects using adipose stem cells from normal and osteoporotic ratsResearch perspectives: The 2013 AAOS/ORS research symposium on Bone Quality and Fracture Prevention.Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.Serum sclerostin levels in renal cell carcinoma patients with bone metastasesTenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivoEndocrinology of anorexia nervosa in young people: recent insights.Treadmill running exercise prevents senile osteoporosis and upregulates the Wnt signaling pathway in SAMP6 mice.Isopsoralen-mediated suppression of bone marrow adiposity and attenuation of the adipogenic commitment of bone marrow-derived mesenchymal stem cells.Focal bone involvement in inflammatory arthritis: the role of IL17.Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Stapled peptides: providing the best of both worlds in drug development.Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia.Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis.Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model.Excessive Activation of TLR4/NF-κB Interactively Suppresses the Canonical Wnt/β-catenin Pathway and Induces SANFH in SD Rats.Genetic architecture of bone quality variation in layer chickens revealed by a genome-wide association study.Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells.Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization.Higher circulating parathormone is associated with smaller and weaker bones in obese children.Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth.Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.
P2860
Q26748699-61E6EF78-3F69-428E-B9CF-E1D0F8ADCEDEQ26799815-3DB88968-B101-4BE1-863B-CC1FF0A8CC66Q28247445-102CBD7E-F024-46BF-AED5-9318101DA7EDQ33564617-BA6CCB5D-9F26-4E10-A465-58055748615EQ33651412-825572C3-CE82-47E1-AFEC-BB22EE019042Q33740634-1D93E163-36FA-4E5C-8E51-3610D0464318Q33833409-35D39042-1D51-41C6-BF00-77DB3F2654ACQ34506361-5E9E6D0B-F2F9-4DBE-8612-79ED6BEA52C0Q34545263-3680E35B-9E1D-48A6-9673-AA6C9D4D62F1Q34680463-9B21402B-8804-4990-9F2C-26FD4D8DC69CQ35088791-7D9EE74B-CC08-4C1E-BA6D-140E13D037EAQ35260816-A16CC570-3817-4C2A-9A58-14BD5518FD13Q35739047-68D395AC-07F0-4041-8B29-13CD2E94E418Q36473294-15CF7432-9F61-4F0A-81B5-978D05863673Q36473722-C377E2B1-5A9A-4D76-AE43-52E433D5826CQ36889104-30A4485D-3DC0-4167-AA5D-6ECF1AEF7285Q37282121-61002247-3555-4B89-93C6-7B38F2293A14Q37609123-CE5A3B46-04E9-4804-AAF4-6E1073055A01Q37677831-611DADBD-89C5-414E-84F1-6955E3F760DFQ37687575-858B5D7C-F216-47AC-9048-3D14C29AC463Q37714061-BA9597FC-F311-4FDB-9CE0-1E430953ABCBQ38295616-957745AC-F47F-432F-AC7A-3610E146BAFFQ38343436-A2B18A68-BD23-4311-8661-590F4D7F62DDQ38598245-52262336-898D-4556-8D35-493115C164AEQ38739710-6CE13F6D-6039-4D0F-8F2E-16703E29F088Q38818907-C2370D60-9E0D-4C8F-86B7-C28C00B167D3Q38995852-CB158EAC-5A8A-4B86-B407-B2BD28170A1CQ39289490-D04EC5D1-87DF-4365-9A88-6A911C20C915Q39680232-0F464834-CCE2-4432-9032-8600AB896F39Q40703352-DB8BF86D-9176-4D47-97E5-2611BA743672Q40963107-987386AD-5FF6-4753-80CE-B8EB28C05AF0Q41067642-5D98E02B-0D03-456C-B8D9-0389687EF3FAQ41453417-BC1ED1C9-15EF-43ED-9B18-36B102819E0DQ41773935-537421DA-9971-4968-B393-604E72C739EAQ42292645-B31E8B68-B934-4D76-BD6B-938441E24806Q42705272-0E5D94AD-6DA6-471F-96F4-19F4849EA764Q43787080-A547E084-2CD4-4122-A016-8EDDE80017A0Q45340912-21D07D41-7B26-43F2-8C07-A84EC9D149B2Q46282119-C92E35BA-2560-4BB7-9A9F-4F7A9742BE00Q47104810-E051D1FA-9F43-4667-BBA7-17C2DD1D22C1
P2860
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
@en
type
label
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
@en
prefLabel
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
@en
P1476
Involvement of WNT/β-catenin signaling in the treatment of osteoporosis
@en
P2093
Silvano Adami
P2888
P304
P356
10.1007/S00223-013-9749-Z
P407
P577
2013-06-11T00:00:00Z
P6179
1018257615